Search by Drug Name or NDC

    NDC 68001-0326-00 Desmopressin Acetate 0.2 mg/1 Details

    Desmopressin Acetate 0.2 mg/1

    Desmopressin Acetate is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by BluePoint Laboratories. The primary component is DESMOPRESSIN ACETATE.

    Product Information

    NDC 68001-0326
    Product ID 68001-326_0c4edd95-d523-f96b-e063-6394a90a419b
    Associated GPIs 30201010100320
    GCN Sequence Number 019597
    GCN Sequence Number Description desmopressin acetate TABLET 0.2 MG ORAL
    HIC3 P2B
    HIC3 Description ANTIDIURETIC AND VASOPRESSOR HORMONES
    GCN 26172
    HICL Sequence Number 002841
    HICL Sequence Number Description DESMOPRESSIN ACETATE
    Brand/Generic Generic
    Proprietary Name Desmopressin Acetate
    Proprietary Name Suffix n/a
    Non-Proprietary Name Desmopressin Acetate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 0.2
    Active Ingredient Units mg/1
    Substance Name DESMOPRESSIN ACETATE
    Labeler Name BluePoint Laboratories
    Pharmaceutical Class Factor VIII Activator [EPC], Increased Coagulation Factor VIII Activity [PE], Increased Coagulation Factor VIII Concentration [PE], Vasopressin Analog [EPC], Vasopressins [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA201831
    Listing Certified Through n/a

    Package

    NDC 68001-0326-00 (68001032600)

    NDC Package Code 68001-326-00
    Billing NDC 68001032600
    Package 100 TABLET in 1 BOTTLE (68001-326-00)
    Marketing Start Date 2017-04-30
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.39796
    Pricing Unit EA
    Effective Date 2022-11-23
    NDC Description DESMOPRESSIN ACETATE 0.2 MG TB
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2022-11-23
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis